ICL’s expertise in RECIST protocols

ICL’s expertise in RECIST protocols

ICL has over 8 years experience and expertise in providing scientific, interpretative, analytical and regulatory support to oncology trials on some of the latest pharmaceutical drugs and biomarkers with a seamless in-house technology platform and inherent flexibility...